Drugs News and Research

RSS

X-ray laser-based technology enables faster structural analysis of receptor proteins

An international team of scientists has learnt how to determine the spatial structure of a protein obtained with an X-ray laser using the sulfur atoms it contains. This development is the next stage in the project of a group led by Vadim Cherezov to create an effective method of studying receptor proteins.

30 Sep 2016

TB Alliance announces release of new TB medicines for Kenyan children

TB Alliance is proud to announce the launch of new medicines for childhood tuberculosis (TB) in Kenya, marking the first national roll out of these products.

30 Sep 2016

DHA intake can prevent known trigger of lupus, study finds

A team of Michigan State University researchers has found that consuming an omega-3 fatty acid called DHA, or docosahexaenoic acid, can stop a known trigger of lupus and potentially other autoimmune disorders.

30 Sep 2016

New approach bolsters protein in blood vessels to protect against cerebral malaria

Boosting a protective protein to stabilize blood vessels weakened by malaria showed improved survival beyond that of antimalarial drugs alone in pre-clinical research.

30 Sep 2016

Immunotherapy already in clinical trials for cancer could slow progression of Parkinson's disease

Researchers at Johns Hopkins report they have identified a protein that enables a toxic natural aggregate to spread from cell to cell in a mammal's brain — and a way to block that protein's action.

29 Sep 2016

Combined treatment using complementary medicine and standard care helps reduce preoperative anxiety

A new study conducted at the University of Haifa has some complementary things to say about complementary medicine.

29 Sep 2016

HPV vaccine can decrease incidence of cervical pre-cancers among young women, research shows

Every 20 minutes, someone in the United States receives a cancer diagnosis related to human papillomavirus. HPV causes cancer of the cervix, anus and throat.

29 Sep 2016

ADDF awards $2.1 million grant for clinical study of cancer drug in Alzheimer's patients

The Alzheimer's Drug Discovery Foundation announces a $2.1 million grant awarded to R. Scott Turner, MD, PhD, of Georgetown University Medical Center to conduct a phase II clinical trial of low-dose nilotinib (marketed as Tasigna for use as a cancer therapy) in patients with Alzheimer's disease.

29 Sep 2016

Bioactive compound from neem plant shows promising effects on prostate cancer

A team of international researchers led by Associate Professor Gautam Sethi from the Department of Pharmacology at the Yong Loo Lin School of Medicine at the National University of Singapore has found that nimbolide, a bioactive terpenoid compound derived from Azadirachta indica or more commonly known as the neem plant, could reduce the size of prostate tumour by up to 70 per cent and suppress its spread or metastasis by half.

29 Sep 2016

Recycling existing drugs may help fight several types of cancer

Researchers at the University of Bergen have discovered that a drug against kidney cancer possibly can fight several types of cancer.

29 Sep 2016

Researchers discover how signals from infectious bacteria get to inflammasome sensors

Researchers at St. Jude Children's Research Hospital have discovered the way signals from infectious bacteria gain entry into the cytoplasm of host cells to activate disease-fighting inflammasomes.

29 Sep 2016

Alcohol produces same neural and molecular changes as rapid antidepressant drugs

Can having a few drinks help people with clinical depression feel better? Yes. At least in terms of biochemistry.

28 Sep 2016

FDA approves Medtronic's ‘artificial pancreas’ for type 1 diabetes patients

The U.S. Food and Drug Administration today approved Medtronic's MiniMed 670G hybrid closed looped system, the first FDA-approved device that is intended to automatically monitor glucose (sugar) and provide appropriate basal insulin doses in people 14 years of age and older with type 1 diabetes.

28 Sep 2016

Penn researchers search twitter for tweets about cardiovascular disease

For years, marketers and other commercial data-miners have been using Twitter's vast database of "tweets" to gauge consumer attitudes and track events. Now medical researchers are getting in on the trend.

28 Sep 2016

Specific HPV strain linked to better overall survival for oropharyngeal cancer patients

When it comes to cancer-causing viruses like human papillomavirus, or HPV, researchers are continuing to find that infection with one strain may be better than another.

28 Sep 2016

New study reveals endocrine biological function of brown adipose tissue

Brown adipose tissue -main organ generating heat in the body- is also an endocrine organ that secretes signaling factors that activate the fat and carbohydrates metabolism.

28 Sep 2016

First generation antibiotics show promise for tuberculosis therapy

First generation cephalosporins—antibiotics introduced as a treatment against bacterial infections in 1963—now show promise for tuberculosis (TB) therapy, according to new research published in Scientific Reports.

28 Sep 2016

Tau PET imaging in Alzheimer's disease increases opportunities for developing effective drugs

Tau PET is a new and promising imaging method for Alzheimer's disease. A case study from Lund University in Sweden now confirms that tau PET images correspond to a higher degree to actual changes in the brain. According to the researchers behind the study, this increases opportunities for developing effective drugs.

28 Sep 2016

Aflatoxin exposure can weaken airways' defenses opening door for severe respiratory diseases

Toxins from mold found growing on nuts or corn can weaken the airways' self-clearing mechanisms and immunity, opening the door for respiratory diseases and exacerbating existing ones, suggests a study in Nature Scientific Reports published this month from otolaryngology researchers at the Perelman School of Medicine at the University of Pennsylvania.

27 Sep 2016

Combination of different drugs could improve effect of immunotherapy on skin cancer

The results of studies involving researchers from the MedUni Vienna and Vienna General Hospital Comprehensive Cancer Center show that the effect of immunotherapy on malignant melanoma (black skin cancer) can be improved by combining it with other cancer treatments.

27 Sep 2016

Drugs News and Research

X-ray laser-based technology enables faster structural analysis of receptor proteins

TB Alliance announces release of new TB medicines for Kenyan children

DHA intake can prevent known trigger of lupus, study finds

New approach bolsters protein in blood vessels to protect against cerebral malaria

Immunotherapy already in clinical trials for cancer could slow progression of Parkinson's disease

Combined treatment using complementary medicine and standard care helps reduce preoperative anxiety

HPV vaccine can decrease incidence of cervical pre-cancers among young women, research shows

ADDF awards $2.1 million grant for clinical study of cancer drug in Alzheimer's patients

Bioactive compound from neem plant shows promising effects on prostate cancer

Recycling existing drugs may help fight several types of cancer

Researchers discover how signals from infectious bacteria get to inflammasome sensors

Alcohol produces same neural and molecular changes as rapid antidepressant drugs

FDA approves Medtronic's ‘artificial pancreas’ for type 1 diabetes patients

Penn researchers search twitter for tweets about cardiovascular disease

Specific HPV strain linked to better overall survival for oropharyngeal cancer patients

New study reveals endocrine biological function of brown adipose tissue

First generation antibiotics show promise for tuberculosis therapy

Tau PET imaging in Alzheimer's disease increases opportunities for developing effective drugs

Aflatoxin exposure can weaken airways' defenses opening door for severe respiratory diseases

Combination of different drugs could improve effect of immunotherapy on skin cancer

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News